Global menu

Our global pages

Close

Eversheds Madrid wins ground-breaking pharmaceutical patents dispute

  • Spain

    19-02-2014

    The Madrid office of global law firm Eversheds has successfully represented pharmaceutical company MSD Spain in a landmark patent dispute, setting a new precedent for patent infringement cases.

    The Madrid Commercial Court ordered generic drug companies Chemo Iberica and Quimica Sintetica to pay MSD Spain damages of €20m for infringement of the Losartan patent. Losartan is commercially known as the hypertension medication Cozaar. This ground-breaking decision represents the largest pharmaceutical patent infringement award in Spanish Judicial history.

    The Eversheds Nicea team, led by partners Kiko Carrión and José Mariano Cruz, acted for MSD Spain.

    Kiko Carrión commented:

    “This award is thanks to several years of hard work and dedication. I would like to particularly thank the team for their efforts.”

    Irene Andrés Justi, MSD Managing Counsel for Spain Portugal & Greece, commented:

    “This is an excellent result after a long, difficult case that dates back 2006. Eversheds Nicea’s Patent Litigation team worked hand-in-hand with MSD’s team at all times. Kiko and his team went the extra mile and really made the difference.”

    Disclaimer

    This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

    < Go back

    Print Friendly and PDF
    Register to receive regular updates via email.